IL-4 agonist (Bayer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIL-4 agonist (Bayer)
Drug Alias NameIL-4 muteins (Bayer)interleukin 4 agonist (Bayer)interleukin 4 muteins (Bayer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-4 receptors stimulants
TargetsInterleukin-4 receptors
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A